Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sonim Technologies ( (SONM) ) has issued an announcement.
Effective February 9, 2026, DNA X, Inc. appointed executive chairman Mike Mulica as acting chief executive officer and principal executive officer, formalizing his expanded leadership role after serving in various positions at the company since April 2021. In connection with the appointment, the company raised Mulica’s annual base salary to $450,000 from January 30, 2026, awarded 50,000 restricted stock units vesting monthly over one year, and agreed to reimburse up to 12 months of COBRA premiums following a qualifying termination, underscoring efforts to secure executive stability.
On February 9, 2026, the company also amended the employment agreement of Chief Financial Officer Clay Crolius, designating the January 23, 2026 asset sale as a triggering event under his contract and granting him 35,000 restricted stock units vesting monthly over one year. The amendment further provides up to six months of COBRA premium reimbursement after termination, signaling enhanced retention incentives and continuity in financial leadership as DNA X navigates post-transaction restructuring and strategic repositioning.
The most recent analyst rating on (SONM) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Sonim Technologies stock, see the SONM Stock Forecast page.
Spark’s Take on SONM Stock
According to Spark, TipRanks’ AI Analyst, SONM is a Neutral.
The score is held down primarily by weak financial performance—heavy losses, substantial cash burn, and negative equity—despite a sharp revenue rebound. Technicals show mixed trend conditions with overbought momentum, while corporate events provide some support via balance-sheet simplification and potential Nasdaq compliance improvements; valuation is constrained by negative earnings.
To see Spark’s full report on SONM stock, click here.
More about Sonim Technologies
DNA X, Inc., formerly Sonim Technologies, Inc., is a Delaware corporation historically focused on mobile and related technology, operating in communications and device solutions for enterprise and specialized markets. The company’s leadership changes and compensation structures reflect ongoing realignment following its recent strategic transactions and asset sales.
Average Trading Volume: 57,863
Technical Sentiment Signal: Sell
Current Market Cap: $8.84M
Learn more about SONM stock on TipRanks’ Stock Analysis page.